Cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic hematopoietic stem cell transplantation: viremia, immunogenicity and survival outcomes in a randomised phase 1b trial

Cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic hematopoietic stem cell transplantation: viremia, immunogenicity and survival outcomes in a randomised phase 1b trial

Bibliographic Details
Main Authors: Nakamura, Ryotaro, La Rosa, Corinna, Longmate, Jeffrey, Drake, Jennifer, Slape, Cynthia, Zhou, Qiao, Lampa, Melanie G., O'Donnell, Margaret, Cai, Ji-Lian, Farol, Len, Salhotra, Amandeep, Snyder, David S., Aldoss, Ibrahim, Forman, Stephen J., Miller, Jeffrey S., Zaia, John A., Diamond, Don J.
Format: Online
Language:English
Published: 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926626/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926626/

Similar Items